These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 23758507)

  • 1. Proarrhythmic effect of pacing mode reprogramation in a patient with a congenital long-QT syndrome.
    Di Cori A; Zucchelli G; Romano S; Bongiorni MG
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1304-5. PubMed ID: 23758507
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventricular arrhythmias after leadless pacemaker implantation, a case report and systematic review of the literature.
    Aparisi Á; Sandín-Fuentes M; García-Granja PE; García-Morán E; Rubio J
    J Cardiovasc Electrophysiol; 2020 Jan; 31(1):227-228. PubMed ID: 31808227
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequent Premature Ventricular Contraction and Non-Sustained Ventricular Tachycardia After the SARS-CoV-2 Vaccination in Patient With Implantable Cardioverter Defibrillator Due to Acquired Long-QT Syndrome.
    Aiba T; Ishibashi K; Hattori K; Wada M; Ueda N; Miyazaki Y; Wakamiya A; Yamagata K; Inoue Y; Miyamoto K; Nagase S; Kusano K
    Circ J; 2021 Oct; 85(11):2117. PubMed ID: 34275963
    [No Abstract]   [Full Text] [Related]  

  • 4. Pacing for prevention of ventricular arrhythmias: time for a pause.
    Wilber DJ
    Heart Rhythm; 2006 May; 3(5):581-2. PubMed ID: 16648065
    [No Abstract]   [Full Text] [Related]  

  • 5. Images in cardiovascular medicine. Polymorphic ventricular tachycardia induced by left ventricular pacing.
    Rivero-Ayerza M; Vanderheyden M; Verstreken S; de Zutter M; Geelen P; Brugada P
    Circulation; 2004 Jun; 109(23):2924-5. PubMed ID: 15197157
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventricular fibrillation induced by short-long-short sequence during managed ventricular pacing.
    Sekita G; Hayashi H; Nakazato Y; Daida H
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1181. PubMed ID: 21453370
    [No Abstract]   [Full Text] [Related]  

  • 7. The R-on-T phenomenon in patients with implantable cardioverter-defibrillators.
    Fries R; Steuer M; Schäfers HJ; Böhm M
    Am J Cardiol; 2003 Mar; 91(6):752-5. PubMed ID: 12633818
    [No Abstract]   [Full Text] [Related]  

  • 8. Fourteen-year follow-up in a teenager with congenital long QT syndrome masquerading as idiopathic generalized epilepsy.
    Chuang WY; Chuang YT; Ueng KC
    J Am Board Fam Med; 2009; 22(3):331-4. PubMed ID: 19429740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irregular ventricular activation results in QT prolongation and increased QT dispersion: a new insight into the mechanism of AF-induced ventricular arrhythmogenesis.
    Akoum NW; Sanders NA; Wasmund SL; Hamdan MH
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1249-52. PubMed ID: 21668564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case report: Delayed detection of ventricular tachycardia due to intradevice interactions by implantable atrio-ventricular pacer/cardioverter defibrillator.
    Kantharia BK; Padder FA
    J Interv Card Electrophysiol; 2006 Aug; 16(2):135-8. PubMed ID: 17016683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pacemaker-mediated tachycardia with varying cycle length: what is the mechanism?
    Verrijcken A; Huybrechts W; Willems R
    Europace; 2009 Oct; 11(10):1400-2. PubMed ID: 19578056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular storm following late presentation acute myocardial infarction.
    Ihsan J; Khand A; Adlan AM
    Heart; 2020 Sep; 106(18):1399-1448. PubMed ID: 32847930
    [No Abstract]   [Full Text] [Related]  

  • 13. The onset mechanisms of ventricular tachycardia.
    Ulus T; Kudaiberdieva G; Gorenek B
    Int J Cardiol; 2013 Aug; 167(3):619-23. PubMed ID: 23040077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device therapy in the setting of long QT syndrome.
    Rhodes T; Weiss R
    Card Electrophysiol Clin; 2015 Sep; 7(3):479-86. PubMed ID: 26304528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ventricular arrhythmias in the congenital long QT syndrome.
    Viskin S; Fish R
    Curr Cardiol Rep; 2000 Nov; 2(6):492-7. PubMed ID: 11060576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazards of antitachycardia pacing to treat ventricular tachycardias with implantable cardioverter defibrillators.
    Maass AH; Van Gelder IC
    Europace; 2009 Jun; 11(6):819. PubMed ID: 19357140
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of T-wave oversensing in an infant with an implanted defibrillator.
    Czosek RJ; Anderson JB; Cao J; Knilans TK
    Heart Rhythm; 2010 Oct; 7(10):1516-7. PubMed ID: 20493275
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric arrhythmias.
    Hanisch D
    J Pediatr Nurs; 2001 Oct; 16(5):351-62. PubMed ID: 11598867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators.
    Himmrich E; Przibille O; Zellerhoff C; Liebrich A; Rosocha S; Andreas K; Nebeling D; Omogbehin B; Meyer J
    Circulation; 2003 Jul; 108(2):192-7. PubMed ID: 12835212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.